Sector
PharmaceuticalsOpen
₹4,972.1Prev. Close
₹5,059.35Turnover(Lac.)
₹468.02Day's High
₹5,100Day's Low
₹4,970.0552 Week's High
₹5,17052 Week's Low
₹3,800.1Book Value
₹821.6Face Value
₹10Mkt Cap (₹ Cr.)
23,179.92P/E
42.4EPS
119.23Divi. Yield
0.6915 May 2023
12:00 AM
Dividend
Dividend Amount: 35
Record Date: 11 Aug, 2023
6 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
27 Jul 2023
12:00 AM
AGM
Announcement Date: 27 Jul, 2023
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 45.75 | 45.75 | 45.75 | 45.75 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 3,161.55 | 2,818.66 | 2,347.29 | 3,349.74 |
Net Worth | 3,207.3 | 2,864.41 | 2,393.04 | 3,395.49 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 2,610.99 | 2,238.55 | 2,151.65 | 1,968.51 |
yoy growth (%) | 16.63 | 4.03 | 9.3 | 0.11 |
Raw materials | -948.03 | -797.74 | -792.4 | -739.68 |
As % of sales | 36.3 | 35.63 | 36.82 | 37.57 |
Employee costs | -403.67 | -361.06 | -364.51 | -314.29 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 772.89 | 668.72 | 642.49 | 547.91 |
Depreciation | -115 | -109.41 | -103.24 | -66.25 |
Tax paid | -160.33 | -171.11 | -133.36 | -187.84 |
Working capital | 385.47 | -980.02 | 712.61 | 190.64 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 16.63 | 4.03 | 9.3 | 0.11 |
Op profit growth | 17.35 | 24.37 | 14.44 | 43.29 |
EBIT growth | 14.55 | 4.66 | 19.15 | 41.55 |
Net profit growth | 23.1 | -2.26 | 41.39 | 6.91 |
| Particulars (Rupees in Crores.) | Nov-2009 | Nov-2008 | Nov-2007 | Nov-2006 | Nov-2005 |
|---|---|---|---|---|---|
Gross Sales | 772.27 | 681.7 | 676.69 | 770.59 | 702.34 |
Excise Duty | 0 | 0 | 0 | 60.4 | 54.15 |
Net Sales | 772.27 | 681.7 | 676.69 | 710.2 | 648.17 |
Other Operating Income | 24.37 | 22.89 | 0 | 0 | 0 |
Other Income | 71.05 | 278.01 | 343.07 | 59.59 | 41.06 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Company Sec. & Compli. Officer
Prajeet Nair
Independent Director
Uday Khanna
Independent Director
Sunil Lalbhai
Executive Director (Finance)
MILIND ANIL PATIL
Independent Director
MEENA GANESH
Executive Director
Samir Kazi
Chairman & Independent Directo
Pradip P Shah
Managing Director
Meenakshi Nevatia
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Pfizer Ltd
Summary
Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company offer a portfolio of 150 specialised medicines in 15 therapeutic areas across 4 business categories. It has its own manufacturing facility at Goa and Thane. It has the distinction of being the first pharmaceutical company in India to start clinical research. The Company sells products in nearly 185 countries having 43 manufacturing sites globally. Their 6 primary therapeutic areas includes, Internal Medicine, Oncology, Hospital, Vaccines, Inflammation & Immunology and Rare Diseases.Pfizer Limited came to the Indian market in 21st November, 1950 through a company named Dumex Limited. The first production facility was set up at Darukhanna in Mumbai, where products like Protinex and Isonex (isoniazid - an anti -TB drug) were manufactured. Subsequently, this plant also produced Becosules and Corex. In 1960, Pfizer established a large and modern plant at Thane, near Mumbai, which housed manufacturing, quality control and product research facilities. This plant won a number of national safety awards. In November of the year 1965, the Company had entered into a licence agreement with Pfizer Corporation continuing the royalty-free licence granted to it for the use of Pfizer processes, technical know-how, etc., relating to the manufacture of existing products in the pharmaceutical, veterinary and agricultural fields and giving the Company the right to obtain from Pfizer Co
Read More
What is the Pfizer Ltd share price today?
The Pfizer Ltd shares price on N/A is Rs.₹5049.05 today.
What is the Market Cap of Pfizer Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Pfizer Ltd is ₹23098.26 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Pfizer Ltd?
The PE and PB ratios of Pfizer Ltd is 42.4 and 6.43 as of 22 Jul ‘24
What is the 52 Week High and Low of Pfizer Ltd?
The 52-week high/low is the highest and lowest price at which a Pfizer Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Pfizer Ltd is ₹3800 and ₹5172.6 as of 22 Jul ‘24
What is the CAGR of Pfizer Ltd?
Pfizer Ltd's CAGR for 5 Years at 9.78%, 3 Years at -3.72%, 1 Year at 30.75%, 6 Month at 18.20%, 3 Month at 22.70% and 1 Month at 4.65%.
What is the shareholding pattern of Pfizer Ltd?
The shareholding pattern of Pfizer Ltd is as follows:
Promoters - 63.92 %
Institutions - 18.66 %
Public - 17.42 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
